Summary of Bill HRES 516
Bill 117 H.Res. 516, titled "Supporting the designation of July 2021 as Uterine Fibroids Awareness Month," is a resolution introduced in the US Congress to raise awareness about uterine fibroids, a common health issue affecting many women. The resolution aims to educate the public about the prevalence of uterine fibroids, which are non-cancerous growths in the uterus that can cause symptoms such as heavy menstrual bleeding, pelvic pain, and infertility.
The resolution highlights the need for increased research funding and access to treatment options for women with uterine fibroids. It also recognizes the impact that uterine fibroids can have on women's physical and emotional well-being, as well as their quality of life.
By designating July 2021 as Uterine Fibroids Awareness Month, the resolution seeks to bring attention to this important health issue and encourage discussions about prevention, diagnosis, and treatment options. It also calls on healthcare providers, researchers, and policymakers to work together to improve outcomes for women affected by uterine fibroids.
Overall, Bill 117 H.Res. 516 aims to promote awareness, education, and advocacy around uterine fibroids, with the ultimate goal of improving the lives of women who are impacted by this condition.
Congressional Summary of HRES 516
This resolution expresses support for the goals and ideals of Uterine Fibroids Awareness Month. Uterine fibroids are muscular tumors that grow in the wall of the uterus and may cause pain, heavy menstrual bleeding, and reproductive issues.